CAS 804518-63-6
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 10 prodotti.
2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl
CAS:Formula:C24H33N5O4SPurezza:99%Colore e forma:SolidPeso molecolare:487.6149Ref: IN-DA00GAHY
5mgPrezzo su richiesta10mgPrezzo su richiesta250mgPrezzo su richiesta25mg180,00€50mg222,00€1mg359,00€100mg526,00€2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
CAS:2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-oneFormula:C24H33N5O4SPurezza:98%Peso molecolare:487.63Ref: 4Z-Y-001002
5mgPrezzo su richiesta100mgPrezzo su richiesta10mg2.144,00€25mg3.766,00€50mg6.276,00€Ref: 4Z-Y-001003
5mgPrezzo su richiesta100mgPrezzo su richiesta10mg2.144,00€25mg3.766,00€50mg6.276,00€Ref: 4Z-Y-001001
5mgPrezzo su richiesta100mgPrezzo su richiesta10mg1.429,00€25mg2.620,00€50mg4.108,00€Yonkenafil
CAS:Yonkenafil is a potent, selective inhibitor of the enzyme cGMP-specific phosphodiesterase type 5 (PDE5). It is used for the treatment of erectile dysfunction. Yonkenafil has been shown to inhibit nitric oxide synthase (NOS) activity, which may be responsible for its neuroprotective effect. This compound also inhibits microglia activation and neuronal death in vitro and in vivo. Yonkenafil has been shown to be effective in the treatment of Parkinson's disease symptoms, such as cognitive impairment and motor deficits.Formula:C24H33N5O4SPurezza:Min. 95%Peso molecolare:487.6 g/molRef: ST-EA-CP-Y2000
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaYonkenafil
CAS:Yonkenafil (Tunodafil) is a PDE5 inhibitor that improves neurological outcomes and cognitive function in models.Formula:C24H33N5O4SPurezza:99.99%Colore e forma:Yellow SolidPeso molecolare:487.61
